Copyright Reports & Markets. All rights reserved.

Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Gastroenteropancreatic Neuroendocrine Tumor
      • 1.4.3 Foregut Neuroendocrine Tumor
      • 1.4.4 Midgut Neuroendocrine Tumor
      • 1.4.5 Hindgut Neuroendocrine Tumor
    • 1.5 Market by Application
      • 1.5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2019-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size
    • 2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Regions
      • 2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2019-2025)
      • 2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by by Players
      • 3.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by by Players (2014-2019)
      • 3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
    • 3.3 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product/Solution/Service
    • 3.4 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2014-2019)
    • 4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 5.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in North America
    • 5.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 5.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    6 Europe

    • 6.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 6.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Europe
    • 6.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 6.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    7 China

    • 7.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 7.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in China
    • 7.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 7.4 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    8 Japan

    • 8.1 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 8.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Japan
    • 8.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 8.4 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 9.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Southeast Asia
    • 9.3 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 9.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    10 India

    • 10.1 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 10.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in India
    • 10.3 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 10.4 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2014-2019)
    • 11.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Central & South America
    • 11.3 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
    • 11.4 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Peptide Receptor Radionuclide Therapy (PRRT) Introduction
      • 12.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2014-2019))
      • 12.1.5 Novartis Recent Development
    • 12.2 ITM Solucin
      • 12.2.1 ITM Solucin Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Introduction
      • 12.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2014-2019)
      • 12.2.5 ITM Solucin Recent Development
    • 12.3 National Institutes of Health
      • 12.3.1 National Institutes of Health Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Introduction
      • 12.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2014-2019)
      • 12.3.5 National Institutes of Health Recent Development
    • 12.4 Australasian Gastro-Intestinal Trials Group
      • 12.4.1 Australasian Gastro-Intestinal Trials Group Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Peptide Receptor Radionuclide Therapy (PRRT) Introduction
      • 12.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2014-2019)
      • 12.4.5 Australasian Gastro-Intestinal Trials Group Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Novartis
      ITM Solucin
      National Institutes of Health
      Australasian Gastro-Intestinal Trials Group
      ...

      Market segment by Type, the product can be split into
      Gastroenteropancreatic Neuroendocrine Tumor
      Foregut Neuroendocrine Tumor
      Midgut Neuroendocrine Tumor
      Hindgut Neuroendocrine Tumor

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players.
      To present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Peptide Receptor Radionuclide Therapy (PRRT) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now